Company intelligence / Profile preview

Ophtha

Gentofte, Denmark

Ownership: Private
Development stage: Other

Overview

Ophtha A/S was a Danish pharmaceutical company specializing in the development and marketing of ophthalmic products. Founded in 2001, the company focused on eye care solutions, including lubricants and anti-inflammatory treatments. It became a wholly-owned subsidiary of the Actavis Group in the mid-2000s, serving as a key vehicle for Actavis's expansion into the Nordic ophthalmology market. Following the acquisition of Actavis by Watson Pharmaceuticals (later Allergan and then Teva), Ophtha's operations and product portfolio were integrated into the parent company's global generic and specialty pharma divisions.

Therapeutic areas: Ophthalmology
Modalities: Small molecule
Industry: Biotech

Partnerships

Actavis Group

Beyond the preview

Go deeper on Ophtha.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ophtha.

Explore the full profile